Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Lumicell logo — Illuminate Cancer in Real Time

Lumicell

Illuminate Cancer in Real Time

Founded 2009 United States Waltham, United States 63 employees Venture round Total: $80.49M Biotechnology, Hardware +1

General Information

Company Name Lumicell
Founded Year 2009
Location United States Waltham, United States
Founders / Decision Makers
Team member
Employees 63
Industries Biotechnology, Hardware, Health Care
Funding Stage Venture round
Business Model B2B, B2B2C
Revenue Model Product Sales, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Lumicell. To contact Lumicell, visit lumicell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Lumicell compare?

A PDF of Lumicell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Lumicell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Lumicell

Lumicell, with the slogan "Illuminate Cancer in Real Time," is a transformative player in the Biotechnology, Hardware, and Health Care sectors. Founded in 2009 and based in the United States, this privately held company is pioneering fluorescence-guided technologies aimed at enhancing cancer surgery outcomes.

The company’s flagship product, the Lumicell Direct Visualization System, is designed to illuminate cancerous tissues within the breast cavity during initial lumpectomies, thereby potentially reducing the need for repeat surgeries. Additionally, Lumicell is exploring its proprietary optical imaging agent across a diverse array of solid tumor types, demonstrating significant versatility in oncologic applications.

Recently, Lumicell secured a $2.73M Venture Round investment on 24 July 2024, underscoring investor confidence in its mission to refine cancer treatment standards while reducing healthcare costs.

Business keywords: Cancer Surgery, Fluorescence-Guided Technology, Image-Guided Surgery, Real-Time Illumination, Breast Cancer Surgery, Optical Imaging Agent, Solid Tumor Indications, Cancer Cell Illumination, Surgical Device Development, Cancer Resection, Clinical Investigation, Oncologic Imaging, Fluorescent Optical Contrast, Positive Margin Reduction

Services & Products

Real-time cancer detection
Lumpectomy assistance
Fluorescence imaging technology

Target Customers

Healthcare providers Surgeons Cancer treatment facilities Biotech and Medtech professionals

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed -
24 Jul 2024
Venture Round $2.73M -
24 Jul 2024
Debt Financing $9.00M 1
Intuitive Venture Partners
Intuitive Venture Partners
01 Sep 2022
Debt Financing $34.80M 1
Intuitive Venture Partners
Intuitive Venture Partners
01 Aug 2021
Series C $28.70M 3
LaunchCapital BlueIO Kodiak Venture Partners
LaunchCapital, BlueIO +1
24 Oct 2017
Venture Round $1.56M -
25 Feb 2014
Grant $994.17K 1
National Science Foundation
National Science Foundation
10 Apr 2012
Seed Round $2.70M 1
Rivas Capital
Rivas Capital
02 Jun 2011

Lumicell Alternatives & Competitors

View All Alternatives
Lumicell vs
Dilon Technologies Inc.
Dilon Technologies Inc. United States

Dilon Technologies is a medical device company that focuses on products that assist in the fight aga...

Debt Financing
74 employees
Biotechnology, Health Care
Compare Lumicell vs Dilon Technologies Inc.
Lumicell vs
OncoRes Medical
OncoRes Medical Australia

Transforming the standard of care in breast cancer surgery.

42 employees
Biotechnology, Health Care
Compare Lumicell vs OncoRes Medical
Lumicell vs
Edinburgh Molecular Imaging Ltd
Edinburgh Molecular Imaging Ltd United Kingdom

Founded in 2014, Edinburgh Molecular Imaging (EM Imaging) is a clinical phase biotechnology company...

Venture round
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About Lumicell

Illuminate Cancer in Real Time
Lumicell was founded in 2009.
Lumicell is headquartered in Waltham, United States.
Lumicell operates in Biotechnology, Hardware and Health Care. Its work centres on Cancer Surgery, Fluorescence-Guided Technology, Image-Guided Surgery and Real-Time Illumination. Its customers include Healthcare providers, Surgeons and Cancer treatment facilities.
Lumicell has a B2B and B2B2C business model. Its revenue comes from Product Sales and Usage Based.
Lumicell has approximately 63 employees.
Lumicell has completed 8 funding rounds, raising a total of $80.49M. The latest funding stage is Venture round.
Lumicell offers: Real-time cancer detection, Lumpectomy assistance, Fluorescence imaging technology.
Top alternatives and competitors to Lumicell include Dilon Technologies Inc., OncoRes Medical, Edinburgh Molecular Imaging Ltd, Vergent Bioscience, Suros Surgical Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lumicell and Dilon Technologies Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lumicell, https://bouncewatch.com/company/lumicell, updated 10 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout